Dr. Mi-Hyeon Jang has had a longstanding interest in the field of regenerative medicine. The focus of research in Jang laboratory is to understand the underlying neurobiological mechanisms that promote regenerative processes of adult neurogenesis, oligodendrogenesis and myelination. We hope to discover novel regenerative strategies for improving learning and memory function in brain aging, as well as neurological and neurodegenerative disorders. Building on my earlier work in brain aging, Jang laboratory pursues a new direction focused on chemotherapy-induced cognitive impairment (also known as chemobrain) which resembles the brain aging process. Given that multiple molecular pathways contribute to the pathogenesis of chemobrain, we aim to uncover the molecular contributors driving chemobrain to direct development of rationally designed synergistic “disease-modifying therapeutic strategies” to ameliorate chemobrain, thus ultimately improving quality of life for cancer survivors. Dr. Jang is a core member of Rutgers Brain Health Institute (BHI) and an active full member of the Cancer Pharmacology Program at Cancer Institute of New Jersey (CINJ).
Program Faculty
- Mi-Hyeon Jang
- Associate Professor
- Department: Department of Neurosurgery
- Graduate Program(s): Cell and Developmental Biology
- Major Research Interest(s): Aging, Drug Discovery, Learning / memory, Neuroscience, Stem Cells, Regeneration, and Tissue Injury
- Research Techniques: Bioinformatics / Computational, Cell Biology, Genetics, Imaging, Single Cell RNA Techniques
- Research Organism(s): in vitro, Mice
- Phone: 1.7322354372
- Email:
This email address is being protected from spambots. You need JavaScript enabled to view it. - Robert Wood Johnson Medical School
- RWJMS Staged Research Building, Rooms 143, 144
- 661 Hoes Lane West
- Piscataway, NJ 08854-8021
- Key Words: Adult neurogenesis, oligodendrogenesis, regenerative neurobiology, brain development, brain aging & chemobrain
- Lab Site URL